National Institute on Drug Abuse; Notice of Closed Meeting

Published date10 December 2021
Citation86 FR 70511
Record Number2021-26819
SectionNotices
CourtNational Institutes Of Health
Federal Register, Volume 86 Issue 235 (Friday, December 10, 2021)
[Federal Register Volume 86, Number 235 (Friday, December 10, 2021)]
                [Notices]
                [Pages 70511-70512]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2021-26819]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Institute on Drug Abuse; Notice of Closed Meeting
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of the following meeting.
                 The meeting will be closed to the public in accordance with the
                provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended. The grant applications and the discussions could
                disclose confidential trade secrets or commercial property such as
                patentable material, and personal information concerning
                [[Page 70512]]
                individuals associated with the grant applications, the disclosure of
                which would constitute a clearly unwarranted invasion of personal
                privacy.
                 Name of Committee: National Institute on Drug Abuse Special
                Emphasis Panel; Mechanistic Studies on the Impact of Social
                Inequality on the Substance Use Trajectory.
                 Date: February 3, 2022.
                 Time: 10:00 a.m. to 5:30 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, National Institute on Drug
                Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
                Meeting).
                 Contact Person: Rebekah Feng, Ph.D., Scientific Review Officer,
                Scientific Review Branch, National Institute on Drug Abuse, NIH,
                3WFN 09C49, MSC 6021, 301 North Stonestreet Avenue, Rockville, MD
                20892, (301) 827-7245, [email protected].
                (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
                Abuse Scientist Development Award for Clinicians, Scientist
                Development Awards, and Research Scientist Awards; 93.278, Drug
                Abuse National Research Service Awards for Research Training;
                93.279, Drug Abuse and Addiction Research Programs, National
                Institutes of Health, HHS)
                 Dated: December 7, 2021.
                Tyeshia M. Roberson-Curtis,
                Program Analyst, Office of Federal Advisory Committee Policy.
                [FR Doc. 2021-26819 Filed 12-9-21; 8:45 am]
                BILLING CODE 4140-01-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT